Effects of linoleic acid and mitogenic stimulation on the fatty acid composition of human lymphocytes.
Perturbation of the fatty acid composition of human lymphocytes in vitro was investigated by addition of linoleic acid complexed to bovine serum albumin (BSA-LA) and by mitogenic stimulation with phytohaemagglutinin (PHA). BSA-LA resulted in a 45% increase in linoleic acid in phosphatidylethanolamine (PE) and over 100% in phosphatidylcholine (PC) in peripheral blood cells. Supplementation with BSA-LA in PHA-stimulated lymphocytes produced even greater changes: 100% increase in linoleic acid content for PE and over 300% for PC. There was a large decrease in oleic acid: 40% for PE and almost 100% in PC. Significant decreases in arachidonic acid occurred in both phospholipid fractions. PHA alone also altered membrane phospholipid fatty acid composition, with reductions in palmitic, stearic and linoleic acid for PE and increases in oleic acid and arachidonic acid (almost 100%). For PC, there were large decreases in stearic (40%), linoleic (30%) and arachidonic (40%) acids, together with an increase in oleic acid (65%). Cells supplemented with linoleic acid grown in the presence of PHA, compared with those grown in linoleic acid-supplemented medium alone, showed a 40% decrease in palmitic acid and a 55% increase in arachidonic acid in PE. For PC, there were large decreases in stearic acid (40%) and arachidonic acid (57%). Antibody-induced redistribution of surface molecules ('capping') was inhibited by some 14% after incubation with BSA-LA. However, no consistent alterations in PHA-induced cell proliferation were observed. These data suggest that profound alterations of membrane fatty acid composition occur spontaneously during the mitotic cycle, and may be further induced by experimental manipulation, without gross perturbation of cell function.
Shires
S E
SE
Department of Medicine, St. James's University Hospital, Leeds, U.K.
Kelleher
J
J
Trejdosiewicz
L K
LK
D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000097:blood; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D005227:Fatty Acids / Q000097:blood*; D006801:Humans; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000097:blood / Q000494:pharmacology*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism*; D008563:Membrane Lipids / Q000097:blood; D008934:Mitogens / Q000494:pharmacology*; D019301:Oleic Acid; D009829:Oleic Acids / Q000097:blood; D019308:Palmitic Acid; D010169:Palmitic Acids / Q000097:blood; D010713:Phosphatidylcholines / Q000097:blood; D010714:Phosphatidylethanolamines / Q000097:blood; D010835:Phytohemagglutinins / Q000494:pharmacology; D012710:Serum Albumin, Bovine / Q000494:pharmacology; D013229:Stearic Acids / Q000097:blood
D001095:Arachidonic Acids; D005227:Fatty Acids; D008041:Linoleic Acids; D008563:Membrane Lipids; D008934:Mitogens; D009829:Oleic Acids; D010169:Palmitic Acids; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010835:Phytohemagglutinins; D013229:Stearic Acids; D012710:Serum Albumin, Bovine; D016718:Arachidonic Acid; D019301:Oleic Acid; D019308:Palmitic Acid; C031183:stearic acid; D019787:Linoleic Acid